ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd (SHA:603976)

SHA:603976 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	167.99	325.08	108.9	187.62	212.43	392.17
Short-Term Investments	-	156.59	-	-	-	-
Trading Asset Securities	151.47	-	140.58	250.11	159.06	254.76
Cash & Short-Term Investments	319.46	481.67	249.48	437.73	371.49	646.93
Cash Growth	29.46%	93.07%	-43.01%	17.83%	-42.58%	140.23%
Accounts Receivable	363.58	338.59	364.58	397.91	355.53	298.37
Other Receivables	4.46	4.29	4.15	5.51	20.26	2.86
Receivables	368.04	342.88	368.73	403.42	375.8	301.23
Inventory	194.34	230.39	250.48	197.14	209.43	190.5
Other Current Assets	12.32	8.45	7.17	12.87	35.03	12.45
Total Current Assets	894.15	1,063	875.86	1,051	991.75	1,151
Property, Plant & Equipment	784.8	782.23	859.67	919.49	909.85	665.86
Long-Term Investments	150.15	-	0.05	0.05	0.05	0.05
Other Intangible Assets	37.79	38.31	39.36	40.41	41.6	42.98
Long-Term Deferred Tax Assets	9.02	9.34	8.82	12.65	1.13	5.89
Long-Term Deferred Charges	1.95	1.64	2.23	2.74	3.9	4.27
Other Long-Term Assets	37.96	6.66	170.82	16.38	59.41	90.33
Total Assets	1,916	1,902	1,957	2,043	2,008	1,960

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	225.18	191.8	240.47	313.88	296.65	278.36
Accrued Expenses	18.82	25.58	22.81	23.82	20.68	26.4
Short-Term Debt	-	-	-	30	60	50
Current Portion of Leases	3.02	0.06	0.06	0.2	0.37	0.32
Current Income Taxes Payable	-	1.45	0.92	3.3	0.98	13.28
Current Unearned Revenue	6.58	4.19	3.39	4.61	6.77	6.76
Other Current Liabilities	2.17	2.06	2.43	3.63	4.22	3.06
Total Current Liabilities	255.77	225.14	270.08	379.44	389.66	378.18
Long-Term Debt	440.01	445.94	431.99	416.25	399.27	382.32
Long-Term Leases	-	0.01	0.03	0.06	0.54	0.91
Long-Term Unearned Revenue	25.32	25.3	31.3	31.61	28.63	30.72
Long-Term Deferred Tax Liabilities	-	-	-	-	5.37	2.4
Total Liabilities	721.11	696.39	733.4	827.37	823.47	794.53

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	152.27	151.2	151.2	151.2	151.2	151.2
Additional Paid-In Capital	577.18	555.71	555.63	555.63	555.63	555.59
Retained Earnings	442.37	473.93	492.22	484.34	453.03	434.82
Comprehensive Income & Other	22.89	24.34	24.35	24.35	24.35	24.35
Shareholders' Equity	1,195	1,205	1,223	1,216	1,184	1,166
Total Liabilities & Equity	1,916	1,902	1,957	2,043	2,008	1,960

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	443.02	446.01	432.08	446.51	460.17	433.55
Net Cash (Debt)	-123.57	35.66	-182.6	-8.78	-88.68	213.38
Net Cash Growth	-	-	-	-	-	-2.81%
Net Cash Per Share	-0.86	0.25	-1.20	-0.06	-0.59	1.42
Filing Date Shares Outstanding	152.27	151.2	151.2	151.2	151.2	151.2
Total Common Shares Outstanding	152.27	151.2	151.2	151.2	151.2	151.2
Working Capital	638.38	838.26	605.78	671.72	602.08	772.92
Book Value Per Share	7.85	7.97	8.09	8.04	7.83	7.71
Tangible Book Value	1,157	1,167	1,184	1,175	1,143	1,123
Tangible Book Value Per Share	7.60	7.72	7.83	7.77	7.56	7.43
Buildings	460.17	459.38	466.94	467.67	362.71	359.42
Machinery	1,000	933.13	902.78	926.75	734.29	608.03
Construction In Progress	22.09	35.27	52.03	10.97	198.58	20.21

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 14, 2026

Data Sources Report a data error